CPC A61K 47/14 (2013.01) [A61K 9/0075 (2013.01); A61K 45/06 (2013.01)] | 21 Claims |
1. A dry powder inhalation formulation comprising at least one active pharmaceutical ingredient (API) and a lipid matrix comprising a mixture of monohydroxystearin, dihydroxystearin, and trihydroxystearin, wherein said dry powder inhalation formulation has a weight ratio between said at least one API and said lipid matrix: between 0.1/99.9 and 88/12.
|